Test Price
1,000 AED✅ Home Collection Available
Neisseria meningitidis Bacterial Load Test in UAE | 1000 AED | DHA Licensed
Executive Summary & Core Metrics
Precision‑grade Neisseria meningitidis bacterial load quantification via ISO‑accredited qPCR and confirmatory Whole Genome Sequencing. 99.9% diagnostic sensitivity. Hospital extraction only – sample collection is conducted strictly within an accredited hospital facility; mobile home phlebotomy is disabled for safety. Telephonic post‑test clinical guidance and direct insurance billing verification on WhatsApp +971 54 548 8731. Fully compliant with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields.
Test Overview & Methodology
Comprehensive Overview of Neisseria meningitidis Bacterial Load Quantification
This state‑of‑the‑art molecular assay accurately quantifies meningococcal DNA in CSF, blood, or nasopharyngeal swabs, empowering clinicians to distinguish colonization from invasive disease and monitor therapeutic response. It combines real‑time PCR (qPCR) with confirmatory Whole Genome Sequencing, providing unmatched antimicrobial resistance profiling and epidemiological typing for UAE public health surveillance.
| Feature | Our Test (qPCR + WGS) | Conventional Culture |
|---|---|---|
| Diagnostic Sensitivity | 99.9% (analytical sensitivity ≤5 copies/reaction) | 50–80% (prior antibiotic exposure reduces yield) |
| Methodology | Real‑Time PCR (TaqMan) + Illumina‑based WGS | Chocolate agar culture, biochemical ID, serogrouping |
| Turnaround Time | Phone notification within 24 h; final report 3rd working day | 3–5 days (up to 7 for serotyping) |
| Antimicrobial Resistance Insight | WGS detects penA, rpoB, gyrA mutations conferring resistance | Separate MIC testing required, additional 2 days |
| Price (AED) | 1000 | 400–600 (excluding confirmatory tests) |
All prices inclusive of hospital‑based collection, cold‑chain transport, and tele‑guidance.
Physician Insight & Safety Protocols
“This molecular test is essential for rapidly identifying invasive meningococcal disease. I always emphasise that a positive PCR warrants immediate specialist referral, while negative results must still correlate with clinical signs—particularly in patients who have received partial antibiotic therapy. Our team provides complimentary telephonic interpretation to ensure every result is clinically actionable and no patient is left without clarity.”
Medication Advisory
Do not discontinue prescribed antibiotics or any maintenance medication without explicit consent of your treating physician. Abrupt cessation may precipitate life‑threatening complications.
Safety Exclusion Criteria & Emergency Red Flags
- Exclusion for CSF collection: international normalized ratio (INR) > 1.5, platelet count < 50,000/µL, known intracranial space‑occupying lesion, suspected raised intracranial pressure without prior neuroimaging clearance.
- Exclusion for nasopharyngeal swab: recent epistaxis or nasal trauma, anticoagulant therapy without medical clearance (minimal risk).
- ER Red Flags – seek immediate emergency care if: sudden severe headache, fever >39°C, neck stiffness, photophobia, altered consciousness, petechial/purpuric rash, or new‑onset seizures. These may indicate rapidly progressive meningococcal disease requiring urgent hospital intervention.
Patient FAQ & Clinical Guidance
1. What is the Neisseria meningitidis bacterial load test and why is it performed?
This quantitative PCR test measures the amount of meningococcal bacteria in CSF, blood, or a nasopharyngeal swab. It helps physicians differentiate between asymptomatic carriage and invasive disease, guide antibiotic therapy, and monitor treatment response. The numerical result (copies/mL) is critical for deciding hospital admission, intensity of antimicrobial therapy, and infection control measures mandated by UAE public health guidelines.
2. How should I prepare for the test, and is home sample collection available in the UAE?
No special fasting is required, but you must disclose all anticoagulant medications. Because the primary sample (CSF) requires a lumbar puncture, specimen collection is performed only in an accredited hospital setting by qualified medical staff. For blood or nasopharyngeal swab samples, the same hospital‑based protocol applies. Please bring any prior clinical records and a signed consent form (provided digitally). Our cold‑chain logistics preserve specimen integrity from the hospital to the ISO‑certified laboratory.
3. What do the results mean, and when can I expect them?
A high bacterial load (e.g., >10³ copies/mL) typically indicates acute invasive disease requiring immediate treatment. Low‑level positivity may reflect carriage or early infection. Whole Genome Sequencing adds serogroup and resistance gene data. Preliminary results are phoned within 24 hours; the final comprehensive report is available by the third working day. A physician will call you as soon as critical results are available to ensure no delay in clinical decision‑making.
UAE Regulatory & Data Privacy Adherence
This test is performed at DNA Labs UAE, a DHA‑licensed facility compliant with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All patient data are encrypted and handled in accordance with strict confidentiality protocols. The laboratory holds ISO 9001:2015 certification (certificate: INT/EGQ/2509DA/3139). For insurance billing verification, contact us on WhatsApp +971 54 548 8731.
Clinical & Logistical Metadata
| Test Name | Neisseria meningitidis Bacterial Load Quantification (qPCR + WGS) |
| Price (AED) | 1000 |
| Turnaround Time | 24‑hour preliminary; final report in 3rd working day |
| Sample Type / Matrix | CSF, Blood, Nasopharyngeal swab (collection in hospital setting only) |
| Methodology Used | Real‑Time PCR (TaqMan) + Illumina‑based Whole Genome Sequencing |
| ICD-10-CM Code | A39.0 (Meningococcal meningitis) |
| LOINC Code | 92431-6 (Neisseria meningitidis DNA [log10 copies/mL] in Cerebral spinal fluid by NAA with probe detection) |
| DHA Facility License & Address | License No. 1143, Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians